 <h1>Syntocinon Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>oxytocin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about oxytocin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Syntocinon.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to oxytocin: parenteral injection</i></p><p>Side effects include:</p><p>Adverse effects usually are dose related. </p><p>Uterine hyperstimulation and subsequent fetal heart rate deceleration most common. (See Uterine Hyperactivity under General Precautions.)</p><p>Maternal nausea, vomiting, sinus bradycardia, premature ventricular complexes; probably related to labor and not the drug. </p><p>Neonatal hyperbilirubinemia, jaundice, retinal hemorrhage, low Apgar scores at 5 minutes. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to oxytocin: compounding powder, injectable solution, intravenous solution</i></p><h3>General</h3><p>The more commonly reported adverse effects have included headache, tachycardia, bradycardia, nausea and vomiting.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, bradycardia </p><p><b>Frequency not reported</b>: Premature ventricular contractions, hypertensive episodes, cardiac arrhythmia, bradycardia (neonate), premature ventricular contractions and other arrhythmias (neonate) </p><p><b>Postmarketing reports</b>: Myocardial ischemia, QTc prolongation, hypotension, flushing<sup>[Ref]</sup></p><p>Bradycardia and premature ventricular contractions and other arrhythmias have been reported in the neonate due to induced uterine motility.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Permanent CNS or brain damage, and seizures have been reported in the neonate due to induced uterine motility.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache </p><p><b>Frequency not reported</b>: Subarachnoid hemorrhage, permanent CNS or brain damage (neonate), neonatal seizures<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Severe water intoxication with convulsions, coma, fatal water intoxication</p><p><b>Postmarketing reports</b>: Maternal hyponatremia, neonatal hyponatremia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reaction </p><p><b>Postmarketing reports</b>: Anaphylactic reaction and shock<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Uterine Rupture, pelvic hematoma, postpartum hemorrhage</p><p><b>Postmarketing reports</b>: Uterine hypertonicity, tetanic contractions, rupture of the uterus; fetal distress (neonate), amniotic fluid embolism<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Fatal afibrinogenemia</p><p><b>Postmarketing reports</b>: Disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Neonatal jaundice has been reported in the neonate due to use of oxytocin (the active ingredient contained in Syntocinon) in the mother.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Neonatal jaundice<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Postmarketing reports</b>: Acute pulmonary edema, asphyxia (neonate)</p><h3>Ocular</h3><p><b>Frequency not reported</b>: Neonatal retinal hemorrhage<sup>[Ref]</sup></p><p>Neonatal retinal hemorrhage has been reported in the neonate due to use of oxytocin in the mother.<sup>[Ref]</sup></p><h3>Other</h3><p>Fetal death has been reported due to induced uterine motility; low Apgar scores at 5 minutes have been reported in the neonate due to oxytocin (the active ingredient contained in Syntocinon) use in the mother.</p><p><b>Frequency not reported</b>: Fetal death, low Apgar scores at 5 minutes</p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Angioedema</p><p id="ref_1">1. "Product Information. Syntocinon (oxytocin)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Pitocin (oxytocin)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p><h2>More about Syntocinon (oxytocin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: uterotonic agents</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Labor Induction</li>
<li>Postpartum Bleeding</li>
<li>Abortion</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>